Filana Therapeutics, Inc.
FLNA· Nasdaq
FLNAFilana Therapeutics, Inc.
Filed Jul 26, 2018 · 10-Q · 26 days after period end · 0001069530-18-000031
| Metric | Q2 2018 | Q2 2017 | Q2 2016 | Q2 2015 |
|---|---|---|---|---|
| Net Income | -$2.45M | -$4.16M | -$3.02M | -$3.37M |
| EPS Diluted | -$0.36 | -$0.64 | -$0.46 | -$0.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Filana Therapeutics, Inc. · CIK 1069530 · Engraved from SEC EDGAR
ended Jun 30, 2018 · filed Jul 26, 2018 · 26 d after period end
